Bioceres Crop Solutions (NASDAQ:BIOX) Price Target Cut to $12.50

Bioceres Crop Solutions (NASDAQ:BIOX) had its price objective lowered by Canaccord Genuity Group from $17.00 to $12.50 in a research report report published on Wednesday morning, Benzinga reports. The brokerage currently has a buy rating on the stock.

BIOX has been the topic of several other research reports. Roth Mkm dropped their price objective on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a buy rating on the stock in a report on Wednesday. Roth Capital raised shares of Bioceres Crop Solutions to a strong-buy rating in a research note on Tuesday, July 2nd. Lake Street Capital lowered their price objective on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a buy rating for the company in a research report on Wednesday. Canaccord Genuity Group upgraded shares of Bioceres Crop Solutions to a strong-buy rating in a research note on Friday, July 19th. Finally, Oppenheimer decreased their target price on shares of Bioceres Crop Solutions from $17.00 to $16.00 and set an outperform rating on the stock in a report on Wednesday. Four equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of Buy and a consensus target price of $13.63.

Bioceres Crop Solutions Trading Down 0.5 %

Shares of Bioceres Crop Solutions stock opened at $8.56 on Wednesday. The firm has a market capitalization of $537.57 million, a price-to-earnings ratio of 856.00 and a beta of 0.49. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.83 and a current ratio of 1.28. Bioceres Crop Solutions has a fifty-two week low of $8.16 and a fifty-two week high of $14.05. The stock has a 50 day moving average of $10.43 and a 200 day moving average of $11.41.

Bioceres Crop Solutions (NASDAQ:BIOX) last issued its quarterly earnings data on Monday, September 9th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by ($0.23). Bioceres Crop Solutions had a return on equity of 0.93% and a net margin of 0.68%. The company had revenue of $124.30 million for the quarter, compared to analyst estimates of $126.75 million. During the same quarter in the prior year, the firm earned ($0.06) earnings per share. As a group, research analysts predict that Bioceres Crop Solutions will post 0.81 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the company. Activest Wealth Management purchased a new stake in shares of Bioceres Crop Solutions in the first quarter valued at approximately $30,000. Cape Investment Advisory Inc. purchased a new stake in shares of Bioceres Crop Solutions in the 4th quarter valued at $33,000. Oppenheimer & Co. Inc. purchased a new stake in Bioceres Crop Solutions during the 1st quarter worth about $139,000. Lazard Asset Management LLC acquired a new stake in shares of Bioceres Crop Solutions in the 1st quarter valued at about $212,000. Finally, Ping Capital Management Inc. acquired a new stake in Bioceres Crop Solutions during the 2nd quarter worth approximately $448,000. 17.68% of the stock is currently owned by hedge funds and other institutional investors.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.